These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 22543284

  • 1. Embryo-fetal distribution of a biopharmaceutical IgG2 during rat organogenesis.
    Bowman CJ, King LE, Stedman DB.
    Reprod Toxicol; 2012 Aug; 34(1):66-72. PubMed ID: 22543284
    [Abstract] [Full Text] [Related]

  • 2. Placental transfer of (125)Iodinated humanized immunoglobulin G2Δa in the Sprague Dawley rat.
    Coder PS, Thomas JA, Stedman DB, Bowman CJ.
    Reprod Toxicol; 2013 Jul; 38():37-46. PubMed ID: 23462583
    [Abstract] [Full Text] [Related]

  • 3. Embryo-fetal transfer of bevacizumab (Avastin) in the rat over the course of gestation and the impact of neonatal Fc receptor (FcRn) binding.
    Thorn M, Piche-Nicholas N, Stedman D, Davenport SW, Zhang N, Collinge M, Bowman CJ.
    Birth Defects Res B Dev Reprod Toxicol; 2012 Oct; 95(5):363-75. PubMed ID: 22969064
    [Abstract] [Full Text] [Related]

  • 4. Placental transfer of a fully human IgG2 monoclonal antibody in the cynomolgus monkey, rat, and rabbit: a comparative assessment from during organogenesis to late gestation.
    Moffat GJ, Retter MW, Kwon G, Loomis M, Hock MB, Hall C, Bussiere J, Lewis EM, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2014 Apr; 101(2):178-88. PubMed ID: 24753333
    [Abstract] [Full Text] [Related]

  • 5. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F, Rohatagi S, Pino M, DeLise B, Zhang J, Nguyen M, Guittin P, Barbellion S, Brunel P, Hofmann T, Schmidt J, Wong M, Lockey P, Lerman S, Clark R.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [Abstract] [Full Text] [Related]

  • 6. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages.
    Domoradzki JY, Pottenger LH, Thornton CM, Hansen SC, Card TL, Markham DA, Dryzga MD, Shiotsuka RN, Waechter JM.
    Toxicol Sci; 2003 Nov; 76(1):21-34. PubMed ID: 12915710
    [Abstract] [Full Text] [Related]

  • 7. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
    Ozolins TR, Gupta U.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):161-70. PubMed ID: 15282737
    [Abstract] [Full Text] [Related]

  • 8. Placental transfer of 125 iodinated humanized immunoglobulin G2Δa in the cynomolgus monkey.
    Catlin NR, Mitchell AZ, Potchoiba MJ, O'Hara DM, Wang M, Zhang M, Weinbauer GF, Bowman CJ.
    Birth Defects Res; 2020 Jan 01; 112(1):105-117. PubMed ID: 31746560
    [Abstract] [Full Text] [Related]

  • 9. Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis.
    Bowman CJ, Breslin WJ, Connor AV, Martin PL, Moffat GJ, Sivaraman L, Tornesi MB, Chivers S.
    Birth Defects Res B Dev Reprod Toxicol; 2013 Dec 01; 98(6):459-85. PubMed ID: 24391099
    [Abstract] [Full Text] [Related]

  • 10. Distribution of bisphenol A into tissues of adult, neonatal, and fetal Sprague-Dawley rats.
    Doerge DR, Twaddle NC, Vanlandingham M, Brown RP, Fisher JW.
    Toxicol Appl Pharmacol; 2011 Sep 15; 255(3):261-70. PubMed ID: 21820460
    [Abstract] [Full Text] [Related]

  • 11. The effects of feed restriction during organogenesis on embryo-fetal development in the rat.
    Fleeman TL, Cappon GD, Chapin RE, Hurtt ME.
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct 15; 74(5):442-9. PubMed ID: 16193501
    [Abstract] [Full Text] [Related]

  • 12. Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration.
    Soucy NV, Parkinson HD, Sochaski MA, Borghoff SJ.
    Toxicol Sci; 2006 Mar 15; 90(1):230-40. PubMed ID: 16352619
    [Abstract] [Full Text] [Related]

  • 13. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates.
    Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer GF, Habermann G, Xiao J, Woods C, Grogan J, Gelzleichter T, Cain G.
    Reprod Toxicol; 2016 Aug 15; 63():82-95. PubMed ID: 27211603
    [Abstract] [Full Text] [Related]

  • 14. Methylmercury distribution in the pregnant rat and embryo during early midbrain organogenesis.
    Lewandowski TA, Pierce CH, Pingree SD, Hong S, Faustman EM.
    Teratology; 2002 Nov 15; 66(5):235-41. PubMed ID: 12397631
    [Abstract] [Full Text] [Related]

  • 15. Fetal development in the rat following disruption of maternal renal function during pregnancy.
    Kavlock RJ, Logsdon T, Gray JA.
    Teratology; 1993 Sep 15; 48(3):247-58. PubMed ID: 8248862
    [Abstract] [Full Text] [Related]

  • 16. Effects of feed restriction during organogenesis on embryo-fetal development in rabbit.
    Cappon GD, Fleeman TL, Chapin RE, Hurtt ME.
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct 15; 74(5):424-30. PubMed ID: 16249998
    [Abstract] [Full Text] [Related]

  • 17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 3rd communication: placental transfer and excretion into milk in rats.
    Mizojiri K, Okabe H, Sugeno K, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A.
    Arzneimittelforschung; 1997 Feb 15; 47(2):201-8. PubMed ID: 9079241
    [Abstract] [Full Text] [Related]

  • 18. Ethanol-mediated fetal dysmorphology and its relationship to the ontogeny of maternal liver metallothionein.
    Coyle P, Martin SA, Carey LC, Summers BL, Rofe AM.
    Alcohol Clin Exp Res; 2009 Jun 15; 33(6):1051-8. PubMed ID: 19302082
    [Abstract] [Full Text] [Related]

  • 19. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
    Gómez-Martínez LE.
    Int J Toxicol; 2007 Jun 15; 26(3):237-46. PubMed ID: 17564905
    [Abstract] [Full Text] [Related]

  • 20. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat.
    Clewell RA, Merrill EA, Yu KO, Mahle DA, Sterner TR, Mattie DR, Robinson PJ, Fisher JW, Gearhart JM.
    Toxicol Sci; 2003 Jun 15; 73(2):235-55. PubMed ID: 12700398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.